Figure 2From: Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewResults of multivariable Cox analysis for progression-free survival and overall survival. OX-based, FOLFOX or XELOX; IRI-based, FOLFIRI or XELIRI.Back to article page